Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 5, 1996, Pages 401-405

  Ichikura, T ^a   Tomimatsu, S ^a   Okusa, Y ^a   Yahara, T ^a   Uefuji, K ^a   Tamakuma, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

5 Fluorouracil; Biochemical modulation; Gastric cancer; Leucovorin; Thymidylate synthase

Indexed keywords

FOLINIC ACID; THYMIDYLATE SYNTHASE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CANCER;

ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG COMBINATIONS; FEMALE; HUMANS; LEUCOVORIN; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TEGAFUR; THYMIDYLATE SYNTHASE; URACIL;

EID: 0029762711     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050503     Document Type: Article

References (27)

1. Arbuck SG, Douglas HO Jr, Trave F, Milliron S, Baroni M, Nava H, Emrich LJ, Rustum YM (1987) A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 5:1150-6
2. Doroshow JH, Multhauf P, Leong L, Margolin K, Litchfield T, Akman S, Carr B, Bertrand M, Goldberg D, Blayney D, Obujinrin O, DeLap R, Shuster J, Newman E (1990) Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 8:491-501
3. Erlichman C, Fine S, Wong A, Elhakim T (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6:469-475
4. Evans RM, Laskin JD, Hakara MT (1980) Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. Cancer Res 40:4113-4122
5. Ikenaka K, Tanaka H, Kawai K, Shirasaka T, Fujii S (1983) Studies on the mechanism of cytotoxicity of 5-fluorouracil through impairment of metabolism. Jpn J Cancer Chemother 10 (I):227-231
6. Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma, 1st English edn. Kanehara & Co., Tokyo
7. Kajiyama Y, Tsurumaru M, Ono Y, Udagawa H, Watanabe G, Suzuki M, Matsuda M, Akiyama H (1993) Clinical effect and characteristics of low dose leucovorin and high dose 5-FU therapy in patients with recurrent gastric cancer - a new method of biological modulation. Jpn J Cancer Chemother 20:1797-1801
8. Konishi T, Mafune K, Hiraishi M, Miyama T, Hirata T, Yoshida J, Mori K, Idezuki Y (1990) Sequential methotrexate and 5-fluorouracil in advanced gastric cancer. Jpn Soc Gastroenterol Surg 23:2024-2032
9. Kubota T, Fujita S, Kodaira S, Yamamoto T, Josui K, Arisawa Y, Suto A, Ishibiki K, Abe O, Mabuchi K, Fuse M (1991) Antitumor activity of fluoropyrimidines and thymidylate synthetase inhibition. Jpn J Cancer Res 82:476-482
10. Louvet C, Gramont A de, Demuynck B, Nordlinger B, Maisani JE, Lagadec B, Delfau S, Varette C, Gonzalez-Canali G, Krulik M (1991) High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer. Ann Oncol 2:229-230
11. Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, Fourtillan JB, Gaget H, Mathe G (1986) Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high-dose folic acid. J Clin Oncol 4:685-696
12. Nakamura H, Yu-Qin W, Miyauchi S, Nishioka N, Tanaka H, Harada N, Shirasaka T, Fujii S (1984) Studies on the mechanism of antitumor activity of 5-FU and its derivatives relationship between the inhibition of tumor growth and the inhibition of thymidylate synthase in vivo. Jpn J Cancer Chemother 11:1049-1055
13. O'Connell MJ (1989) A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group Study. Cancer 63:1026-1030
14. Okabe H, Saitou H, Oie S, Nakano K, Uchida J, Takechi T, Takeda S, Kawaguchi Y, Taguchi T (1991) Combination chemotherapy with orally administered UFT and leucovorin. Jpn J Cancer Chemother 18:1645-1650
15. Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV Jr, Markowitz AB, Abbruzzese JL, Bready B, Levin B (1994) Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300
16. Peters GJ, Groeningen CJ, Wilt CL, Meijer S, Smid K, Lanrensse E, Pinedo HM (1992) The course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin. Semin Oncol 19:26 35
17. Petrelli N, Douglass HO, Jr, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Shinella R, Green MD, Muggia FM, Megibow A, Greenwald ES, Bukowski RM, Harris J, Levin B, Gaynor E, Loutfi A, Kalser MH, Barkin JS, Benedetto P, Woolley PV, Nauta R, Weaver DW, Leichman LP. for the Gastrointestinal Tumor Study Group (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7:1419-1426
18. Poon MA, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK, Levitt R, Kardinal CG, Mailliard JA (1991) Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9:1967-1972
19. Saltz LB, Leichman CG, Young CW, Muggia FM, Conti JA, Spiess T, Jeffers S, Leichman LP (1995) A fixed-ratio combination of uracil and Ftorafur with low dose leucovorin. Cancer 75:782-785
20. Sanchiz F, Milla A (1994) Tegafur uracil (UFT) plus folinic acid in advanced rectal cancer. Jpn J Clin Oncol 24:322-326
21. Sasaki E, Namatame K, Nakayosi A (1992) A study of intracellular pharmacodynamics based on thymidylate synthetase inhibition rate in preoperative chemotherapy with 5-FU oral administration for gastric cancer. J Jpn Soc Cancer Ther 27:1155-1165
22. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH (1982) In vivo kinetics of thymidilate synthetase inhibition in 5-Fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res 42:450-456
23. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L, Danenberg PV (1984) Thymidylate synthethase inhibition in malignant tumors and normal liver of patients given intravenous 5-Fluorouracil. Cancer Res 44:4144-4150
24. Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM, Allegra CJ (1989) Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7:890-899
25. Takeda S, Uchida J, Yamada Y, Unemi N, Fujii S (1988) The significance of measuring inhibition of thymidylate synthase activity as a parameter for antitumor activity of 5-fluorouracil derivatives. Jpn J Cancer Chemother 15:2125-2130
26. Ushiyama M (1992) A study on concentration of 5-FU and thymidylate synthase inhibition rate in neoplastic and non-neoplastic tissues related to degeneration of colorectal neoplastic tissue. Niigata Igakkai Zasshi 106:424-435
27. Yagawa A (1990) Histopathological study on antitumor effect of tegafur administered continuous intravenous infusion. J Jpn Soc Cancer Ther 25:1197-1203